Aura Biosciences, INC. (AURA) — 8-K Filings

8-K Filings (12)

• Aura Biosciences Files 8-K on Financials and Operations — Mar 30, 2026 Risk: medium
  Aura Biosciences, Inc. filed an 8-K on March 30, 2026, reporting on its results of operations and financial condition, as well as other events. The filing inclu
• Aura Biosciences Files 8-K on Shareholder Vote Matters — Jun 18, 2025 Risk: low
  Aura Biosciences, Inc. filed an 8-K on June 18, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 17, 2025. The fil
• 8-K Filing — May 16, 2025
• Aura Biosciences Reports Officer/Director Changes & Compensatory Info — Apr 2, 2025 Risk: medium
  Aura Biosciences, Inc. filed an 8-K on April 2, 2025, reporting events as of March 31, 2025. The filing primarily concerns the departure of directors or certain
• Aura Biosciences Files 8-K — Oct 17, 2024 Risk: low
  Aura Biosciences, Inc. filed an 8-K on October 17, 2024, reporting on other events and financial statements. The filing does not contain specific details about
• Aura Biosciences Appoints New Director, Adjusts Executive Pay — Sep 27, 2024 Risk: medium
  Aura Biosciences, Inc. announced on September 23, 2024, changes in its board of directors and executive compensation. Specifically, Dr. David E. Johnson has bee
• Aura Biosciences Files 8-K — Sep 12, 2024 Risk: low
  Aura Biosciences, Inc. filed an 8-K on September 12, 2024, to report on other events and financial statements. The filing does not contain specific financial fi
• Aura Biosciences Files 8-K with Corporate Updates — Jun 21, 2024 Risk: low
  Aura Biosciences, Inc. filed an 8-K on June 21, 2024, reporting events that occurred on June 20, 2024. The filing indicates changes to the company's articles of
• Aura Biosciences Files 8-K Report — Jun 4, 2024 Risk: low
  On June 4, 2024, Aura Biosciences, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating up
• Aura Biosciences Files 8-K for Operations Update — May 9, 2024 Risk: low
  Aura Biosciences, Inc. filed an 8-K on May 9, 2024, to report on its results of operations and financial condition, as well as to file financial statements and
• Aura Biosciences Announces Board and Executive Changes — Apr 15, 2024 Risk: medium
  Aura Biosciences, Inc. announced on April 12, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company reporte
• Aura Biosciences Files 8-K, Confirms Emerging Growth Status — Jan 8, 2024
  Aura Biosciences, Inc. filed an 8-K on January 8, 2024, indicating an 'Other Events' disclosure. This filing, while not detailing specific financial transaction

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX